You are here

  • Home
  • Archive
  • Volume 11, Issue 6
  • Study protocol for SKIPMDD: subcutaneous ketamine infusion in palliative care patients with advanced life limiting illnesses for major depressive disorder (phase II pilot feasibility study)

Article info

Article menu

Download PDFPDF

XML
Palliative care
Protocol
Study protocol for SKIPMDD: subcutaneous ketamine infusion in palliative care patients with advanced life limiting illnesses for major depressive disorder (phase II pilot feasibility study)

Authors

  • Wei Lee Improving Care for Palliative Aged, and Chronic Care through Clinical Research and Translation (IMPACCT), Faculty of Health, University of Technology Sydney, Sydney, New South Wales, AustraliaSt Vincent"s Clinical School, Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Caitlin Sheehan Calvary Hospital, Kogarah, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Richard Chye Palliative Care, St Vincent"s Hospital Sydney, Darlinghurst, New South Wales, AustraliaUniversity of Notre Dame, Darlinghurst, Sydney, Australia PubMed articlesGoogle scholar articles
  • Sungwon Chang Improving Care for Palliative Aged, and Chronic Care through Clinical Research and Translation (IMPACCT), Faculty of Health, University of Technology Sydney, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Colleen Loo Black Dog Institute, Randwick, New South Wales, AustraliaDepartment of Psychiatry, University of New South Wales, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Brian Draper Department of Psychiatry, University of New South Wales, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Meera Agar Improving Care for Palliative Aged, and Chronic Care through Clinical Research and Translation (IMPACCT), Faculty of Health, University of Technology Sydney, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • David C Currow Improving Care for Palliative Aged, and Chronic Care through Clinical Research and Translation (IMPACCT), Faculty of Health, University of Technology Sydney, Sydney, New South Wales, AustraliaCancer Institute New South Wales, St Leonards, New South Wales, Australia PubMed articlesGoogle scholar articles
  1. Correspondence to Dr David C Currow; David.Currow{at}uts.edu.au
View Full Text

Citation

Lee W, Sheehan C, Chye R, et al
Study protocol for SKIPMDD: subcutaneous ketamine infusion in palliative care patients with advanced life limiting illnesses for major depressive disorder (phase II pilot feasibility study)
BMJ Open 2021;11:e052312. doi: 10.1136/bmjopen-2021-052312

Publication history

  • Received April 14, 2021
  • Accepted June 10, 2021
  • First published June 28, 2021.
Online issue publication 
June 28, 2021
Previous versions
Review history

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.